NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Compass Group Diversified Holdings, LLC (NYSE: CODI). Shareholders who purchased shares of CODI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/compass-diversified-loss-submission-form/?id=148466&from=3 CL ...

NEW YORK, May 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Compass Group Diversified Holdings, LLC (NYSE: CODI).Shareholders who purchased shares of CODI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/compass-diversified-loss-submission-form/?id=148444&from=4CLASS PERI ...

NEW ORLEANS, May 14, 2025 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until July 8, 2025 to file lead plaintiff applications in a securities class action lawsuit against Compass Diversified Holdings (NYSE: CODI), if they purchased the Company's securities between May 1, 2024 and May 7, 2025, inclusive (the "Class Period"). This action is pending in the United States District Court for the Central District of California. On May 7, 2025, the Compan ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Compass Diversified due to alleged violations of federal securities laws, with a deadline for investors to seek lead plaintiff status by July 8, 2025 [4]. Group 1: Allegations Against Compass Diversified - The complaint alleges that Compass and its executives made false and misleading statements and failed to disclose irregularities in its subsidiary, Lugano Holdings, Inc., including unrecorded financing arrangements and issues with sales, cost of sales, inventory, and accounts receivable [6]. - It is claimed that the financial statements of Compass were rendered unreliable due to these irregularities, necessitating a restatement of the financials [6]. - The company is accused of failing to maintain adequate internal controls related to its financial statements, leading to materially false and misleading public statements [6]. Group 2: Impact of the Investigation - On May 7, 2025, Compass disclosed that its financial statements for fiscal year 2024 should no longer be relied upon due to an ongoing internal investigation into Lugano Holdings, which identified irregularities in financing, accounting, and inventory practices [7]. - Following this announcement, Compass Diversified's stock price fell by 8% in after-hours trading, resulting in financial harm to investors [8]. Group 3: Legal Proceedings and Investor Actions - Investors who suffered losses exceeding $100,000 in Compass stock or options between May 1, 2024, and May 7, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights [1]. - The role of lead plaintiff in the class action lawsuit is open to any member of the putative class, with the lead plaintiff being the one with the largest financial interest in the relief sought [9].

Core Viewpoint - A securities class action lawsuit has been filed against Compass Diversified Holdings for failing to disclose material information, leading to significant financial losses for investors during the class period from May 1, 2024, to May 7, 2025 [1][3]. Group 1: Lawsuit Details - Investors who purchased securities of Compass during the class period have until July 8, 2025, to file lead plaintiff applications [1][2]. - The lawsuit alleges that Compass and certain executives violated federal securities laws by not disclosing critical information [3]. - Following the announcement of an internal investigation and the need to restate financial statements for fiscal 2024, Compass's share price dropped approximately 62%, from $17.25 on May 7, 2025, to $6.55 on May 8, 2025 [4]. Group 2: Company Background - Compass Diversified Holdings is currently under scrutiny due to irregularities identified in its subsidiary, Lugano Holding, Inc., related to financing, accounting, and inventory practices [4]. - The Audit Committee of Compass's Board has initiated an investigation after concerns were raised about Lugano's financial practices [4]. - Kahn Swick & Foti, LLC, the law firm handling the case, is recognized as one of the top securities litigation firms in the nation, serving various clients seeking recoveries for investment losses [5].

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Compass Diversified Holdings (“CODI” or the “Company”) (NYSE: CODI).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether CODI and certain of it ...

Core Insights - The article expresses cautious optimism regarding Compass Therapeutics (NASDAQ: CMPX) and highlights the importance of an upcoming readout that is expected to occur early in the year [1]. Company Analysis - Compass Therapeutics is under scrutiny for its clinical trials and the potential implications of the results on its stock performance [1]. - The author has a background in biochemistry and extensive experience in analyzing biotech companies, which adds credibility to the insights shared about Compass Therapeutics [1]. Industry Context - The article emphasizes the significance of understanding the science behind biotech investments, suggesting that investors should conduct thorough due diligence to avoid pitfalls in this sector [1].

The complaint alleges that on May 7, 2025, Compass issued an 8-K and attached a press release titled "Compass Diversified Discloses Non-Reliance on Financial Statements for Fiscal 2024 Amid an Ongoing Internal Investigation into its Subsidiary, Lugano Holding, Inc." In this release, Compass announced that it "has preliminarily identified irregularities in Lugano's non-CODI financing, accounting, and inventory practices. After discussing with senior leadership and investigators, the Audit Committee of CODI's ...

Core Viewpoint - A class action lawsuit has been filed against Compass Diversified for allegedly making false and misleading statements regarding its financial practices and internal controls during the specified Class Period [1][3]. Group 1: Lawsuit Details - The lawsuit was filed in the United States District Court for the Central District of California on behalf of all individuals and entities who purchased Compass securities between May 1, 2024, and May 7, 2025 [1]. - Investors have until July 8, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit [1]. Group 2: Allegations Against the Company - The lawsuit claims that Compass's subsidiary, Lugano Holdings, Inc., had unrecorded financing arrangements and irregularities in its sales, cost of sales, inventory, and accounts receivable [3]. - It is alleged that these irregularities rendered the financial statements of Compass unreliable and would necessitate a restatement [3]. - The company is accused of failing to maintain adequate internal controls related to its financial statements, leading to materially false and misleading public statements [3].

Core Viewpoint - Compass Diversified (CODI) is under investigation for potential securities fraud and unlawful business practices following the disclosure of irregularities in its subsidiary, Lugano Holding, Inc. [1][2] Group 1: Investigation Details - Pomerantz LLP is investigating claims on behalf of investors of CODI regarding possible securities fraud or unlawful business practices [1] - On May 7, 2025, CODI announced a non-reliance on its financial statements for fiscal 2024 due to an ongoing internal investigation into Lugano Holding [2] - The Audit Committee of CODI's Board of Directors initiated an investigation after concerns were raised about Lugano's inventory financing practices, which identified irregularities in non-CODI financing, accounting, and inventory practices [2] Group 2: Financial Impact - Following the announcement of the investigation, CODI's stock price dropped by $10.70 per share, representing a decline of 62.03%, closing at $6.55 per share on May 8, 2025 [2]